<DOC>
	<DOCNO>NCT00004373</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine whether benzodiazepine alprazolam reinforce self-medication behavior anxious patient vary history use drug . II . Establish outpatient method study self-medication drug reinforcement patient vulnerable prescription drug abuse dependence . III . Evaluate influence alcohol non-prescription drug use determinant vulnerability patient . IV . Identify personality , attitudinal , variable might predict different pattern self-medication . V. Assess effect cognitive-behavioral therapy alprazolam self-medication .</brief_summary>
	<brief_title>Phase II Double-Blind , Placebo-Controlled Study Reinforcing Effects Alprazolam Patients With Anxiety</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This protocol involve different experiment examine self-medication anxiolytic medication select patient , cognitive-behavioral therapy anxiety . Capsules color cod take double-blind condition . Compliance monitor Medication Event Monitoring System , automatically register date time bottle open . The physician directs therapy administration , use combination follow : blind choice test , antianxiety agent ( ) , placebo , cognitive-behavioral therapy .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Primary diagnosis generalize anxiety panic disorder Determined Structured Clinical Interview DSM IV Hamilton Anxiety Scale ( HAMA ) score least 14 AND Profile Mood States ( POMS ) tension/anxiety scale score least 20 Concurrent diagnosis allow : Mild moderate agoraphobia Simple social phobia Secondary unipolar affective disorder No current substance abuse , dependence , substance abuse treatment Drugfree urine sample require No history primary Axis I diagnosis tobacco dependence Prior/Concurrent Therapy No prior formalize nondrug therapy anxiety disorder No concurrent prescription psychoactive medication No history benzodiazepine dependence Patient Characteristics Age : 18 50 Other : Medically healthy Negative pregnancy test require No occupational requirement work hazardous situation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2003</verification_date>
	<keyword>anxiety disorder</keyword>
	<keyword>disease-related problem/condition</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>panic disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>